Free Trial

Leap Therapeutics (LPTX) SEC Filings & 10K Form

Leap Therapeutics logo
$2.58 -0.01 (-0.39%)
(As of 10:17 AM ET)

Recent Leap Therapeutics SEC Filings

DateFilerForm TypeView
11/15/2024
4:28 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:29 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:30 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:31 PM
CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
5:07 AM
BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Leap Therapeutics (Subject)
Form SC 13G
11/13/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
5:29 PM
BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
Form SC 13D/A
10/31/2024
4:40 PM
BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
Form SCHEDULE 13D/A
10/04/2024
4:22 PM
Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:23 PM
Baum Jason (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:23 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:23 PM
CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:25 PM
Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:25 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:25 PM
Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:26 PM
Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:27 PM
Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:29 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:29 PM
Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:30 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
3:48 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
11:15 PM
Leap Therapeutics (Filer)
Form EFFECT
05/13/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
4:01 PM
Leap Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/09/2024
11:15 PM
Leap Therapeutics (Filer)
Form EFFECT
04/29/2024
3:34 PM
Leap Therapeutics (Filer)
Form DEFA14A
04/29/2024
3:37 PM
Leap Therapeutics (Filer)
Form ARS
04/25/2024
7:39 PM
Leap Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SC 13G
04/19/2024
3:31 PM
GILEAD SCIENCES, INC. (Reporting)
Leap Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/19/2024
3:31 PM
GILEAD SCIENCES, INC. (Filed by)
Leap Therapeutics (Subject)
Form SC 13G
04/11/2024
7:42 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
6:41 AM
Leap Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/18/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
03/18/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/31/2024
8:34 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:34 PM
Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:34 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:34 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:35 PM
Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:35 PM
Baum Jason (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:35 PM
Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:36 PM
Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:36 PM
Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:37 PM
Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:31 PM
CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:32 PM
Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:32 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:33 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
8:33 PM
Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:37 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:38 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:39 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:41 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:42 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
4:28 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
4:10 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LPTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners